Amy Quinlan - Jun 21, 2024 Form 3 Insider Report for Vor Biopharma Inc. (VOR)

Role: Vice President of Finance
Signature: /s/ Katie Kazem, Attorney-in-Fact
Stock symbol: VOR
Transactions as of: Jun 21, 2024
Transactions value $: $0
Form type: 3
Date filed: 6/26/2024, 05:22 PM
Next filing: Sep 4, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VOR	Common Stock						55.8K	Jun 21, 2024	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VOR	Employee Stock Option (right to buy)							Jun 21, 2024	Common Stock	117K	$1.90	Direct	F4
holding	VOR	Employee Stock Option (right to buy)							Jun 21, 2024	Common Stock	29K	$8.63	Direct	F5
holding	VOR	Employee Stock Option (Right to Buy)							Jun 21, 2024	Common Stock	22.5K	$5.55	Direct	F6
holding	VOR	Employee Stock Option (Right to Buy)							Jun 21, 2024	Common Stock	12.5K	$2.41	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 15,000 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in full on September 1, 2024, subject to the Reporting Person's continued service as of each such date.
F2	Includes 7,735 shares underlying RSUs. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in eleven quarterly installments beginning on August 6, 2024, subject to the Reporting Person's continued service as of each such date.
F3	Includes 17,579 shares underlying RSUs. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in fifteen quarterly installments beginning on August 1, 2024, subject to the Reporting Person's continued service as of each such date.
F4	The original option award was for 122,127 shares. 25% of these options vested on August 28, 2021, and the remainder vest over the following three years in equal monthly installments, subject to the Reporting Person's continuous service through each such vesting date.
F5	These options vest over four years in equal monthly installments beginning March 1, 2022, subject to the Reporting Person's continuous service through each such vesting date.
F6	These options vest over four years in equal monthly installments beginning March 6, 2023, subject to the Reporting Person's continuous service through each such vesting date.
F7	These options vest over four years in equal monthly installments beginning March 1, 2024, subject to the Reporting Person's continuous service through each such vesting date.